Form 8-K CVS HEALTH Corp For: Feb 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
FBR Still Impressed with CVS Health (CVS) Following Inline Q4 Results; Affirms at 'Outperform'
February 9, 2016 2:34 PM ESTFBR & Co. reaffirms its Outperform rating and $120 price target on CVS Health (NYSE: CVS) following the retail pharmacy giant's Q4 report earlier Tuesday.
Analyst Steven Halper noted that revenue increased 11 percent and was inline with expectations, as was the company's quarterly... More
